TRAWS PHARMA INC (TRAW) Institutional Ownership Changes & 13F Activity

TRAWS PHARMA INC (TRAW). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ally Bridge Group (Ny) Llc, Orbimed Advisors Llc, Lynx1 Capital Management Lp, Adar1 Capital Management, Llc, and Sphera Funds Management Ltd..

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Ally Bridge Group (Ny) LlcBuy+786,236786,236$663.03KQ2 2026Aug 14, 2026
Orbimed Advisors LlcBuy+597,729+98.7%1,203,260$1.01MQ2 2026Aug 14, 2026
Adar1 Capital Management, LlcBuy+443,631+287.9%597,729$504.06KQ2 2026Aug 14, 2026
Sphera Funds Management Ltd.Buy+398,486398,486$336.04KQ2 2026Aug 14, 2026
Ikarian Capital, LlcSell-200,000-29.5%478,142$403.22KQ2 2026Aug 14, 2026
Jane Street Group, LlcBuy+194,765+916.9%216,006$182.16KQ2 2026Aug 14, 2026
Alyeska Investment Group, L.P.Buy+164,376164,376$138.62KQ2 2026Aug 14, 2026
Hrt Financial LpBuy+91,22091,220$76.00KQ2 2026Aug 14, 2026
Kynam Capital Management, LpBuy+84,40084,400$71.17KQ2 2026Aug 14, 2026
Boothbay Fund Management, LlcSell-60,600-31.2%133,936$112.95KQ2 2026Aug 14, 2026
Xtx Topco LtdBuy+18,09218,092$15.26KQ2 2026Aug 14, 2026
Barclays PlcBuy+1,9471,947$1.64KQ2 2026Aug 14, 2026
Federation Des Caisses Desjardins Du QuebecBuy+500500$414.00Q2 2026Aug 14, 2026
Lynx1 Capital Management LpBuy+544,392+3610.5%559,470$471.80KQ2 2026Aug 13, 2026
Dauntless Investment Group, LlcSell-336,424-80.7%80,574$67.95KQ2 2026Aug 13, 2026
Vanguard Capital Management LlcBuy+274,856+498.0%330,049$278.23KQ2 2026Aug 13, 2026
Northern Trust CorpBuy+37,45437,454$31.59KQ2 2026Aug 13, 2026
Vanguard Fiduciary Trust CoBuy+22,707+71.4%54,511$45.95KQ2 2026Aug 13, 2026
Virtu Financial LlcBuy+12,57912,579$11.00KQ2 2026Aug 13, 2026
Huntington National BankBuy+4,6764,676$3.94KQ2 2026Aug 13, 2026
Morgan StanleySell-3,261-87.4%468$395.00Q2 2026Aug 13, 2026
Ubs Group AgSell-602-14.9%3,451$2.91KQ2 2026Aug 13, 2026
Fmr LlcSell-21-91.3%2$2.00Q2 2026Aug 13, 2026
Geode Capital Management, LlcBuy+34,262+44.4%111,365$93.92KQ2 2026Aug 12, 2026
Harbour Investments, Inc.Buy+55$4.00Q2 2026Aug 12, 2026
Tower Research Capital Llc (Trc)Buy+1,178+29.7%5,142$4.34KQ2 2026Aug 11, 2026
Cassaday & Co Wealth Management LlcSell-5-45.5%6$6.00Q2 2026Aug 10, 2026
Sg Americas Securities, LlcBuy+14,52414,524$12.00KQ2 2026Aug 07, 2026
Blackrock, Inc.Sell-15-0.2%9,941$8.38KQ2 2026Aug 07, 2026
Sbi Securities Co., Ltd.Buy+1,593+1244.5%1,721$1.45KQ2 2026Jul 23, 2026
Showing 30 of 37

Frequently asked questions about TRAW activity

  • Which institutional owners are buying TRAW?

    Institutional owners buying TRAW include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TRAW activity?

    "Buy" means an investor increased their reported position in TRAW compared to the prior reporting period. This reflects growing exposure to TRAWS PHARMA INC (TRAW) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TRAW increasing?

    Institutional interest in TRAW can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.